REGENACY PHARMACEUTICALS
Regenacy Pharmaceuticals they give services to treat diabetic and other peripheral neuropathies.
REGENACY PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Service Industry Therapeutics
Founded:
2016-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.regenacy.com
Total Employee:
1+
Status:
Active
Contact:
(617) 415-5030
Total Funding:
17.11 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Microsoft Exchange Online Office 365 Mail
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Valitor
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..
Current Advisors List
Board_member
2016-01-01
Current Employees Featured
Marc Cohen Co-Founder & Executive Chairman @ Regenacy Pharmaceuticals
Co-Founder & Executive Chairman
2016-01-01
Michelle Hylan Clinical Consultant @ Regenacy Pharmaceuticals
Clinical Consultant
2017-10-01
David Michelson Chief Medical Officer @ Regenacy Pharmaceuticals
Chief Medical Officer
2020-05-01
Simon S. Jones COO & SVP Preclinical Development @ Regenacy Pharmaceuticals
COO & SVP Preclinical Development
2016-12-01
Simon S. Jones President & CEO @ Regenacy Pharmaceuticals
President & CEO
2017-07-01
Founder
Investors List
Cobro Ventures
Cobro Ventures investment in Series B - Regenacy Pharmaceuticals
Taiwania Capital Management Corporation
Taiwania Capital Management Corporation investment in Series B - Regenacy Pharmaceuticals
Yonjin Venture
Yonjin Venture investment in Series B - Regenacy Pharmaceuticals
3E Bioventures
3E Bioventures investment in Series B - Regenacy Pharmaceuticals
3E Bioventures
3E Bioventures investment in Series A - Regenacy Pharmaceuticals
Taya Ventures
Taya Ventures investment in Series A - Regenacy Pharmaceuticals
Cobro Ventures
Cobro Ventures investment in Series A - Regenacy Pharmaceuticals
Taiwania Capital Management Corporation
Taiwania Capital Management Corporation investment in Series A - Regenacy Pharmaceuticals
Rivas Capital
Rivas Capital investment in Series A - Regenacy Pharmaceuticals
Viva Biotech
Viva Biotech investment in Series A - Regenacy Pharmaceuticals
Official Site Inspections
http://www.regenacy.com Semrush global rank: 3.23 M Semrush visits lastest month: 5.15 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Regenacy Pharmaceuticals"
Regenacy Pharmaceuticals - Crunchbase Company …
Organization. Regenacy Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Regenacy Pharmaceuticals - The Org
Regenacy Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company regenerating biological function by protein acetylation for the treatment of diabetic and other peripheral …See details»
Regenacy Pharmaceuticals - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 15, 2022: Series B - …See details»
Regenacy Pharmaceuticals - Leadership Team - The Org
The Leadership Team at Regenacy Pharmaceuticals is responsible for setting the strategic direction of the company and overseeing the development of innovative therapies for chronic …See details»
Regenacy: Revenue, Worth, Valuation & Competitors 2025
About Regenacy. Regenacy is a Biotech related company founded in 2016 and based in Waltham with 11 employees an estimated revenue of $1.7M, and. It has 10 competitors including …See details»
Regenacy Pharmaceuticals, Inc. | LinkedIn
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function ...See details»
Regenacy is poised to deliver the first treatment for
Currently, Regenacy is seeking additional partnerships to develop its portfolio of HDAC inhibitors. ... a non-profit organization serving the hereditary neuropathy patient community, to validate ...See details»
Regenacy Pharmaceuticals CEO and Key Executive Team
Regenacy Pharmaceuticals's President, CEO, and Director is Simon S. Jones. Other executives include John Rocha, Chief Financial Officer; David Michelson, Chief Medical Officer and 1 …See details»
Regenacy Pharmaceuticals Company Profile - Office Locations
Regenacy Pharmaceuticals is a company that develops therapeutic drugs created to treat peripheral neuropathy. It focuses on the development of ricolinostat, an orally bioavailable …See details»
regenacy.com
Regenacy.comSee details»
Regenacy Pharmaceuticals LLC - Company Profile and News
Regenacy Pharmaceuticals, LLC operates as a clinical-stage biopharmaceutical company. The Company develops ricolinostat to treat diabetic, chemotherapy-induced, and inherited …See details»
Regenacy Pharmaceuticals - Overview, News & Similar companies ...
Aug 24, 2022 Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom ma nagement to restore …See details»
Regenacy Pharmaceuticals Announces Collaboration with the …
Waltham, Mass., August 2, 2018 – Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other …See details»
Regenacy Pharmaceuticals - Contacts, Employees, Board …
Organization. Regenacy Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Regenacy Pharmaceuticals has 5 current employee …See details»
Regenacy Pharmaceuticals Announces Completion of Enrollment …
Aug 24, 2022 Regenacy Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company regenerating biological function by protein acetylation for the treatment of diabetic and other …See details»
Regenacy - Company Profile - Tracxn
Oct 23, 2024 Regenacy ranks 66th among 217 active competitors. 81 of its competitors are funded while 43 have exited. Overall, Regenacy and its competitors have raised over $7.24B …See details»
Regenacy Pharmaceuticals Announces Completion of Enrollment …
Aug 31, 2022 Regenacy selectively inhibits histone deacetylase 6 (HDAC6) to restore normal intracellular protein and organelle transport in peripheral neuropathies, and also has a portfolio …See details»
Regenacy is poised to deliver the first treatment for ... - Nature
Currently, Regenacy is seeking additional partner-ships to develop its portfolio of HDAC inhibitors. Recently, the company announced a collaboration with the Charcot–Marie–Tooth Association, …See details»
Regenacy Pharma snags $30M for diabetic neuropathy treatment
Mar 25, 2020 Regenacy’s treatment, ricolinostat, is a pill that inhibits histone deacetylase 6 (HDAC6). Blocking this enzyme restores the function of microtubules, known as the “railways” …See details»
Regenacy Pharmaceuticals | Viva BioInnovator
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore …See details»